Showing results (41-50 of 400) with videos related to
Sort By:
Pageof 40
Pancreas|April 15, 2015
FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studiesFausto Petrelli, Andrea Coinu, Karen Borgonovo, et al.Reviews on Recent Clinical Trials|March 18, 2015
The Modified Glasgow Prognostic Score and Survival in Colorectal Cancer: A Pooled Analysis of the LiteratureFausto Petrelli, Sandro Barni, Andrea Coinu, et al.Clinical Genitourinary Cancer|May 4, 2016
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-AnalysisFausto Petrelli, Andrea Coinu, Ivano Vavassori, et al.Breast Cancer Research and Treatment|November 24, 2021
Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx studySandro Barni, Francesco Cognetti, Fausto PetrelliMedical Oncology (Northwood, London, England)|April 26, 2011
5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trialsFausto Petrelli, Mary Cabiddu, Sandro BarniClinical Breast Cancer|December 31, 2022
Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: a Retrospective Decision Impact AnalysisSandro Barni, Alessandra Fabi, Fausto PetrelliCritical Reviews in Oncology/Hematology|May 5, 2016
Cardiotoxicity of antiemetic drugs in oncology: An overview of the current state of the artSandro Barni, Fausto Petrelli, Mary CabidduEuropean Journal of Cancer (Oxford, England : 1990)|March 7, 2017
Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancersFausto Petrelli, Gianluca Tomasello, Sandro BarniOncology Reviews|May 21, 2015
Axillary dissection compared to sentinel node biopsy for the treatment of pathologically node-negative breast cancer: a meta-analysis of four randomized trials with long-term follow upFausto Petrelli, Veronica Lonati, Sandro BarniExpert Review of Anticancer Therapy|February 6, 2010
Benefit of adjuvant chemotherapy in elderly ER-negative breast cancer patients: benefits and pitfallsSandro Barni, Mary Cabiddu, Fausto PetrelliPageof 40